
Stemcentrx
VerifiedDevelops innovative therapies for cancer
South San Francisco United States (HQ)
Company information
EditDate | Investors | Amount | Round |
---|---|---|---|
- | N/A | - Not yet verified | |
$23.5m | LATE VC | ||
$42m | SERIES D | ||
$200m | SERIES F | ||
$250m | SERIES G | ||
$10.2b Valuation: $10.2b | ACQUISITION | ||
Total Funding | €469m |
Recent News about Stemcentrx
EditLocationEdit
United States, South San Francisco, East Jamie Court